Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA.

Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EM, Worthy G, Landewé R, Smolen JS, Emery P, Buch MH.

Ann Rheum Dis. 2010 Jun;69(6):976-86. doi: 10.1136/ard.2009.126573. Epub 2010 May 6. Review. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

PMID:
20447957
[PubMed - indexed for MEDLINE]
2.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, van Vollenhoven R, Winthrop KL, Wong J, Zink A, van der Heijde D.

Ann Rheum Dis. 2010 Jun;69(6):964-75. doi: 10.1136/ard.2009.126532. Epub 2010 May 5. Review. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

PMID:
20444750
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs.

Bergman GJ, Hochberg MC, Boers M, Wintfeld N, Kielhorn A, Jansen JP.

Semin Arthritis Rheum. 2010 Jun;39(6):425-41. doi: 10.1016/j.semarthrit.2009.12.002. Epub 2010 Mar 11. Review.

PMID:
20223500
[PubMed - indexed for MEDLINE]
4.

Treating rheumatoid arthritis to target: recommendations of an international task force.

Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D; T2T Expert Committee.

Ann Rheum Dis. 2010 Apr;69(4):631-7. doi: 10.1136/ard.2009.123919. Epub 2010 Mar 9. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519. Ann Rheum Dis. @011 Jul;70(7):1349. van der Heijde, Desirée [corrected to van der Heijde, Désirée].

PMID:
20215140
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Tumour necrosis factor alpha -308G->A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis.

Pavy S, Toonen EJ, Miceli-Richard C, Barrera P, van Riel PL, Criswell LA, Mariette X, Coenen MJ.

Ann Rheum Dis. 2010 Jun;69(6):1022-8. doi: 10.1136/ard.2009.117622. Epub 2009 Dec 4. Review.

PMID:
19966089
[PubMed - indexed for MEDLINE]
6.

Biologics for rheumatoid arthritis: an overview of Cochrane reviews.

Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007848. doi: 10.1002/14651858.CD007848.pub2. Review.

PMID:
19821440
[PubMed - indexed for MEDLINE]
7.

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.

Quartuccio L, Fabris M, Salvin S, Atzeni F, Saracco M, Benucci M, Cimmino M, Morassi P, Masolini P, Pellerito R, Cutolo M, Puttini PS, De Vita S.

Rheumatology (Oxford). 2009 Dec;48(12):1557-9. doi: 10.1093/rheumatology/kep314. Epub 2009 Sep 29.

PMID:
19789202
[PubMed - indexed for MEDLINE]
Free Article
8.

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies.

Major EO.

Annu Rev Med. 2010;61:35-47. doi: 10.1146/annurev.med.080708.082655. Review.

PMID:
19719397
[PubMed - indexed for MEDLINE]
9.

Assessing adequate treatment response in patients with rheumatoid arthritis.

Bergman MJ.

Clin Ther. 2009 Jun;31(6):1219-31. doi: 10.1016/j.clinthera.2009.06.005. Review.

PMID:
19695389
[PubMed - indexed for MEDLINE]
10.

Comparative overview of safety of the biologics in rheumatoid arthritis.

Khraishi M.

J Rheumatol Suppl. 2009 Jun;82:25-32. doi: 10.3899/jrheum.090128. Review.

PMID:
19509327
[PubMed - indexed for MEDLINE]
11.

Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?

Bansard C, Lequerré T, Daveau M, Boyer O, Tron F, Salier JP, Vittecoq O, Le-Loët X.

Rheumatology (Oxford). 2009 Sep;48(9):1021-8. doi: 10.1093/rheumatology/kep112. Epub 2009 May 29. Review.

PMID:
19483089
[PubMed - indexed for MEDLINE]
Free Article
12.

Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference.

van Tuyl LH, Vlad SC, Felson DT, Wells G, Boers M.

Arthritis Rheum. 2009 May 15;61(5):704-10. doi: 10.1002/art.24392. Review.

PMID:
19405006
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.

van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Ewals JA, Han KH, Hazes JM, Kerstens PJ, Peeters AJ, van Zeben D, Breedveld FC, Huizinga TW, Dijkmans BA, Allaart CF.

Arthritis Rheum. 2009 Jan 15;61(1):4-12. doi: 10.1002/art.24367.

PMID:
19116965
[PubMed - indexed for MEDLINE]
Free Article
14.

The importance of reporting disease activity states in rheumatoid arthritis clinical trials.

Aletaha D, Funovits J, Smolen JS.

Arthritis Rheum. 2008 Sep;58(9):2622-31. doi: 10.1002/art.23733.

PMID:
18759299
[PubMed - indexed for MEDLINE]
Free Article
15.

European biologicals registers: methodology, selected results and perspectives.

Zink A, Askling J, Dixon WG, Klareskog L, Silman AJ, Symmons DP.

Ann Rheum Dis. 2009 Aug;68(8):1240-6. doi: 10.1136/ard.2008.091926. Epub 2008 Jul 22. Review.

PMID:
18647854
[PubMed - indexed for MEDLINE]
16.

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.

Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, Singh A, Pedersen RD, Koenig AS, Freundlich B.

Lancet. 2008 Aug 2;372(9636):375-82. doi: 10.1016/S0140-6736(08)61000-4. Epub 2008 Jul 16.

PMID:
18635256
[PubMed - indexed for MEDLINE]
17.

Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.

van Tuyl LH, Lems WF, Voskuyl AE, Kerstens PJ, Garnero P, Dijkmans BA, Boers M.

Ann Rheum Dis. 2008 Nov;67(11):1574-7. doi: 10.1136/ard.2008.090712. Epub 2008 Jul 14.

PMID:
18625629
[PubMed - indexed for MEDLINE]
18.

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.

Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A, Alecock E, Lee J, Kremer J.

Ann Rheum Dis. 2008 Nov;67(11):1516-23. doi: 10.1136/ard.2008.092932. Epub 2008 Jul 14. Erratum in: Ann Rheum Dis. 2009 Feb;68(2):296.

PMID:
18625622
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.

Smolen JS, Han C, van der Heijde DM, Emery P, Bathon JM, Keystone E, Maini RN, Kalden JR, Aletaha D, Baker D, Han J, Bala M, St Clair EW; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group.

Ann Rheum Dis. 2009 Jun;68(6):823-7. doi: 10.1136/ard.2008.090019. Epub 2008 Jul 1. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

PMID:
18593759
[PubMed - indexed for MEDLINE]
20.

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, Woodworth T, Alten R; OPTION Investigators.

Lancet. 2008 Mar 22;371(9617):987-97. doi: 10.1016/S0140-6736(08)60453-5.

PMID:
18358926
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk